Common Equity: The sum of all common equity items.
Pelthos Therapeutics Inc. (PTHS) had Common Equity of $58.25M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$7.41M |
|
$-16.24M |
|
$2.32M |
|
$5.09M |
|
$22.77M |
|
$-15.36M |
|
$-1.34M |
|
$-16.70M |
|
$-16.70M |
|
$-16.24M |
|
$-16.24M |
|
$-16.24M |
|
$-16.24M |
|
$-15.36M |
|
$-14.22M |
|
3.06M |
|
3.06M |
|
$-5.30 |
|
$-5.30 |
|
| Balance Sheet Financials | |
$49.76M |
|
$10.17M |
|
$76.67M |
|
$126.43M |
|
$24.77M |
|
-- |
|
$43.41M |
|
$68.18M |
|
|
Common Equity |
$58.25M |
$-4.89M |
|
$58.25M |
|
3.09M |
|
| Cash Flow Statement Financials | |
$-16.34M |
|
$2.76M |
|
$27.32M |
|
$0.51M |
|
$14.25M |
|
$13.74M |
|
$3.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
68.73% |
|
-207.43% |
|
-207.43% |
|
-- |
|
-225.53% |
|
-219.25% |
|
$-16.34M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.10 |
|
0.93 |
|
97.07 |
|
-27.88% |
|
331.86% |
|
-12.84% |
|
-27.88% |
|
$18.85 |
|
$-5.34 |
|
$-5.34 |
|